Answer
The safety of medicinal products to protect patients remains the main objective of Swiss healthcare policy. It provides the overall framework for all the associated optimisation measures. The manufacture of all such products must comply with all the relevant legal provisions and be carried out in accordance with the state of the art in science and technology.